Intelligent Ultrasound Group PLC Notice of Results (1216I)
03 August 2023 - 4:00PM
UK Regulatory
TIDMIUG
RNS Number : 1216I
Intelligent Ultrasound Group PLC
03 August 2023
Intelligent Ultrasound Group plc
(the "Group" or the "Company")
Notice of results
Analyst and investor briefing
Intelligent Ultrasound Group plc (AIM: IUG), the 'classroom to
clinic' ultrasound company, specialising in artificial intelligence
(AI) software and simulation, announces it will issue its interim
results for the six months ended 30 June 2023 on Thursday, 17
August 2023.
A briefing for analysts will be held via video call on 17 August
2023 at 9.30am. To register, please contact
intelligentultrasound@tbcardew.com.
The Company will host a live presentation for investors given by
Stuart Gall and Helen Jones via the Investor Meet Company platform
on Thursday, 17 August 2023 at 5pm. The presentation is open to all
existing and potential shareholders. Questions can be submitted
pre-event via your Investor Meet Company dashboard up until 9am the
day before the meeting or at any time during the live
presentation.
Investors can sign up to Investor Meet Company for free and add
to meet the Company via:
https://www.investormeetcompany.com/intelligent-ultrasound-group-plc/register-investor
Investors who already follow Intelligent Ultrasound on the
Investor Meet Company platform will automatically be invited.
For further information, please contact:
Intelligent Ultrasound Group plc www. intelligentultrasound.com
Stuart Gall, CEO Tel: +44 (0)29 2075 6534
Helen Jones, CFO
Cenkos Securities - Nominated Advisor and
Broker
Giles Balleny/Max Gould (Corporate Finance) Tel: +44 (0)20 7397 8900
Michael Johnson/Julian Morse (Sales)
TB Cardew - PR Advisors Intelligentultrasound@tbcardew.com
Ed Orlebar Tel: + 44 (0)7738 724630
Allison Connolly Tel: +44 (0)7587 453955
Emma Pascoe-Watson Tel: +44 (0)7774 620415
Hero Kurzeja Tel: +44 (0)7827 130430
About Intelligent Ultrasound Group
Intelligent Ultrasound (AIM: IUG) is one of the world's leading
'classroom to clinic' ultrasound companies, specialising in
real-time hi-fidelity virtual reality simulation for the ultrasound
training market ('classroom') and artificial intelligence-based
clinical image analysis software tools for the diagnostic medical
ultrasound market ('clinic'). Based in Cardiff in the UK and
Atlanta in the US, the Group has two revenue streams:
Simulation
Real-time hi-fidelity ultrasound education and training through
simulation. Our main products are the ScanTrainer obstetrics and
gynaecology training simulator, the HeartWorks echocardiography
training simulator, the BodyWorks Eve Point of Care and Emergency
Medicine training simulator with Covid-19 module and the new
BabyWorks Neonate and Paediatric training simulator. To date over
1,500 simulators have been sold to over 750 medical institutions
around the world.
Clinical AI software
Deep learning-based algorithms to make ultrasound machines
smarter and more accessible using our proprietary ScanNav
ultrasound image analysis technology. Current products on the
market utilising this technology are GE Healthcare's SonoLyst
software that is incorporated in their Voluson Expert 22 and SWIFT
ultrasound machines; ScanNav Anatomy PNB that simplifies
ultrasound-guided needling by providing the user with real-time
AI-based
anatomy highlighting for a range of medical procedures; and NeedleTrainer that teaches real-time ultrasound-guided needling and incorporates ScanNav Anatomy PNB.
www.intelligentultrasound.com
NOTE: ScanNav Anatomy PNB is CE approved and cleared for sale in
the US by the FDA, but is not available for sale in any other
territory requiring government approval for this type of
product.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NORGZGGRVZRGFZM
(END) Dow Jones Newswires
August 03, 2023 02:00 ET (06:00 GMT)
Intelligent Ultrasound (LSE:IUG)
Historical Stock Chart
From Aug 2024 to Sep 2024
Intelligent Ultrasound (LSE:IUG)
Historical Stock Chart
From Sep 2023 to Sep 2024